Nathan Treybeck
Stock Analyst at Wells Fargo
(2.49)
# 2,648
Out of 5,042 analysts
19
Total ratings
53.85%
Success rate
14.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITGR Integer Holdings | Downgrades: Equal-Weight | $132 → $80 | $72.91 | +9.72% | 4 | Oct 24, 2025 | |
| RMD ResMed | Initiates: Equal-Weight | $280 | $259.49 | +7.90% | 1 | Oct 13, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $75 → $58 | $34.99 | +65.76% | 8 | Aug 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $130 → $180 | $180.61 | -0.34% | 5 | Aug 1, 2025 | |
| LMAT LeMaitre Vascular | Initiates: Equal-Weight | $95 | $89.21 | +6.49% | 1 | Feb 13, 2025 |
Integer Holdings
Oct 24, 2025
Downgrades: Equal-Weight
Price Target: $132 → $80
Current: $72.91
Upside: +9.72%
ResMed
Oct 13, 2025
Initiates: Equal-Weight
Price Target: $280
Current: $259.49
Upside: +7.90%
PROCEPT BioRobotics
Aug 7, 2025
Maintains: Overweight
Price Target: $75 → $58
Current: $34.99
Upside: +65.76%
iRhythm Technologies
Aug 1, 2025
Maintains: Overweight
Price Target: $130 → $180
Current: $180.61
Upside: -0.34%
LeMaitre Vascular
Feb 13, 2025
Initiates: Equal-Weight
Price Target: $95
Current: $89.21
Upside: +6.49%